Sari la conținut
Home » Blog » 9th INTERNATIONAL ZEUGMA CONFERENCE ON SCIENTIFIC RESEARCH February 19-21, 2023, Gaziantep, Turkey

9th INTERNATIONAL ZEUGMA CONFERENCE ON SCIENTIFIC RESEARCH February 19-21, 2023, Gaziantep, Turkey

A LINK BETWEEN GUT MICROBIOTA AND ALZHEIMER’S DISEASE: IMPACT OF POLENOPLASMIN

Major Gheorghe Giurgiu1, Prof Dr Med Manole Cojocaru2, SciRes I, EuSpLM

1Deniplant-Aide Sante Medical Center, Biomedicine, Bucharest, Romania
deniplant@gmail.com;  Telephone: +4 0744 827 881
https://orcid.org/0000-0002-5449-2712

2Academy of Romanian Scientists

2Titu Maiorescu University, Faculty of Medicine, Bucharest, Romania
cojocaru.manole@gmail.com;  Telephone: +4 0723 326 663
 https://orcid.org/0000-0002-7192-7490

Alzheimer’s disease is a most common neurodegenerative disorder, which associates with impaired cognition.

Gut microbiota can modulate host brain function and behavior via microbiota-gut-brain axis, including cognitive behavior. 

 Antibioticscan induce alterations of gut microbiota and gut physiology and also host cognitive behavior, increasing or decreasing risks of Alzheimer’s disease.

 The increased permeability of intestine and blood-brain barrier induced by gut microbiota disturbance will increase the incidence of neurodegeneration disorders. 

Imbalances in the gut microbiota can be also associated with the neurodegeneration.

There is increasing interest in the role of the peripheral immune system in Alzheimer’s disease pathology. 

We are currently assessing whether indoles can also stimulate formation of neurons in Alzheimer’s disease

Disturbances along the brain-gut-microbiota axis may significantly contribute to the pathogenesis of neurodegenerative disorders.

Alterations in the gut microbiota composition induce increased permeability of the gut barrier and immune activation leading to systemic inflammation, which in turn may impair the blood-brain barrier and promote neuroinflammation, neural injury, and ultimately neurodegeneration. 

Nutrition is known to play an important role in the pathogenesis of Alzheimer’s disease. In addition, the use of nutraceuticals can be part of a comprehensive approach to delay neurodegeneration.

Objective

Modification of the gut microbiota composition by nutraceuticals may create new preventive and therapeutic options in Alzheimer’s disease. 

To arrive at these observations, the authors examined how Polenoplasmin and diet delay neurodegeneration.

Materials and methods

Alzheimer’s disease may begin in the gut, and is closely related to the imbalance of gut microbiota. 

We are currently assessing whether indoles can also stimulate formation of neurons in Alzheimer’s disease.

Gheorghe Giurgiu created the product Polenoplasmin under the license of the Deniplant brand owner Gheorghe Giurgiu.

Polenoplasmin acts as a modulator of the gut microbiome in in Alzheimer’s disease.

Polenoplasminfor Alzheimer’s disease.

Polenoplasmin is a nutraceutical (food with a dual role of nutrition and health) for nerve regeneration.

Polenoplasmin for veterinary use being a food, it is not medically certified, but its components have scientifically proven healing qualities.

It contains freeze-dried pollen from Deniplant plants, carob seed powder, brewer’s yeast.

These findings bring us closer to the possibility of novel treatment options to slow down memory loss, which is a common problem with aging and neurodegenerative diseases including but not limited to Alzheimer’s disease.

These include drugs to mimic the action of indoles to stimulate the production of new neurons in the hippocampus or to replace neurons damaged by Alzheimer’s disease, as well as designing dietary intervention using food products enriched with indoles as a preventive measure to slow down aging.

Results

It has now been shown that microbiota affects brain functions through various metabolites with potentially positive or, conversely, toxic properties.

The immune system has a prominent role in Alzheimer’s disease pathogenesis with both innate and adaptive immunity in the central nervous system. 

Modulation of gut microbiota through personalized diet or beneficial microbiota intervention will probably become a new treatment for Alzheimer’s disease.

There is a strong link between Alzheimer’s disease and chronic inflammation.

Alzheimer’s disease is a neurodegenerative disorder characterized by a progressive decline in memory and thinking severe enough to interfere with daily life. 

Alzheimer’s disease may begin in the gut, and is closely related to the imbalance of gut microbiota. 

Modification of the gut microbiota composition by nutraceuticals may create new preventive and therapeutic options in Alzheimer’s disease. 

Existing evidence suggests that dietary lifestyle changes may affect cognitive function.

Conclusion

The work reported in this paper addresses the formation of neurons in the brain.

We are currently assessing whether indoles can also stimulate early formation of neurons during brain development.

Another area of potential intervention interest is in situations of Alzheimer’s disease where there is an urgent need to generate new neurons.

This study with Polenoplasmin is another intriguing piece of the puzzle highlighting the importance of lifestyle factors and diet.

References

Hu X, Wang T, Jin F. Alzheimer’s disease and gut microbiota. Sci. China Life Sci. 2016, 59, 1006-23.

Jiang C, Li G, Huang P, Liu Z, Zhao B.The Gut Microbiota and Alzheimer’s Disease.J Alzheimers Dis. 2017;58(1):1-15. 

Szablewski L.Human Gut Microbiota in Health and Alzheimer’s Disease.J Alzheimers Dis. 2018;62(2):549-60. 

Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C.Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer’s disease.Life Sci. 2021;264:118627.

Angelucci F, Cechova K, Amlerova J, Hort J.Antibiotics, gut microbiota, and Alzheimer’s disease.J Neuroinflammation. 2019;16(1):108. 

Varesi A, Pierella E, Romeo M, et al. The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment.Nutrients. 2022;14(3):668.

Giurgiu Gheorghe
Author: Giurgiu Gheorghe

2023 Lansare magazin online 2022 Participare conferinte si congrese 2021 deniplant.com 2020 deniplant.eu 2020 Emisiunea Meloterapia si Meloterapia altfel 2020 Imuniplant Cito Remediu natural Anti HPV Oncogen 2019 Infiintarea Centrului de Biomedicina Deniplant- Aide Sante 2018 Grup de sprijin pentru persoanele paralizate. 2018 Neuromodulator al microbiomului. 2018 Artropol pentru afectiunile articulatiilor 2017 Imunomodulator natural al microbiomunui. 2016 Neuropolen - Regenerator natural al celulei nervoase. Remediu natural ce lupta cu paralizia 2015 Infiintarea Centrului de Wellness -Spa Biobreaza 2014 Polenoderm- Pentru o piele curata fara cosuri sau furunculi pe cale naturala . 2014 Sforamin produs nou pentru inlaturarea sforaitului pe cale naturala 2013 Polenoplasmin, pentru tratarea paraliziei la animale. 2012 Antistres Ceai de plante medicinale pentru combaterea efectelor cauzate de stres. 2011 Alergiplant Ceai de plante medicinale pentru alergii. 2010 Stoc caderii parului Plante pentru tinctura. 2010 Imuniplant Ceai de plante medicinale pentru afectiuni autoimune. 2009 Ceai Post operator pentru recuperarea rapida dupa interventii chirurgicale. 2009 Fructimet Ceai dun fructe de padure pentru afectiuni metabolice. 2009 Deniplant a devenit Marca Comunitara Europeana , fiind inregistrata la OHIM detalii.. 2008 Compania Deniplant JA a castigsat cu Deniplant Kids premiul I competitia Company of the Year 2008 organizat de Junior Achievement Romania si...